kyoshino/E+ via Getty Images 7:00 AM MBA Mortgage Applications The Mortgage Bankers' Association compiles various mortgage loan indexes. The purchase applications index measures applications at mortgage lenders. 8:30 AM CPI The CPI is a measure of the change in the average price level of a fixed basket of goods and services purchased by consumers. CPI is seen up 0.5 percent on the month and 4.2 pe...
kyoshino/E+ via Getty Images 7:00 AM MBA Mortgage Applications The Mortgage Bankers' Association compiles various mortgage loan indexes. The purchase applications index measures applications at mortgage lenders. 8:30 AM CPI The CPI is a measure of the change in the average price level of a fixed basket of goods and services purchased by consumers. CPI is seen up 0.5 percent on the month and 4.2 percent on the year as energy prices lift the total. Core CPI is expected at 0.3 percent and 2.9 percent, respectively. Many components are expected to show the impact of higher energy costs, including food, housing, fertilizer, chemicals, metals, and more. 10:30 AM EIA Petroleum Status Report The Energy Information Administration, or EIA, provides weekly information on petroleum inventories in the U.S., whether produced here or abroad. 1:00 PM 10-Yr Note Auction Treasury notes are sold at regularly scheduled public auctions. The competitive bids at these auctions determine the interest rate paid on each Treasury note issue. More on U.S. Markets Downside Risks Rise As Tech Volatility Spikes Markets Rebounding After Friday's Rout Monthly Macro Monitor: Nothing To See Here U.S. economy defies Middle East war as reacceleration takes hold - TS Lombard US2Y hits a fresh 52-week high, extending the sharp 2026 yield rally
Swedish driverless truck group Einride AB will make its trading debut in New York on Wednesday with hopes of benefiting from the investor buzz generated by SpaceX ’s initial public offering later in the week. The high-profile listing of Elon Musk’s company will “absolutely put a spotlight on deep tech” and “the major technological shifts that are taking place,” Einride Chief Executive Officer Rooz...
Swedish driverless truck group Einride AB will make its trading debut in New York on Wednesday with hopes of benefiting from the investor buzz generated by SpaceX ’s initial public offering later in the week. The high-profile listing of Elon Musk’s company will “absolutely put a spotlight on deep tech” and “the major technological shifts that are taking place,” Einride Chief Executive Officer Roozbeh Charli said in an interview. The Stockholm-based startup, founded in 2016, will go public on the Nasdaq through a merger with blank-check firm Legato Merger Corp. III at a pre-money equity valuation of about $1.35 billion. That’s down from the $1.8 billion level announced when the deal was unveiled in November and considerably lower than the roughly $5 billion valuation when discussions took place with banks about a potential IPO, the Financial Times reported . The company agreed to a lower valuation to appeal to investors participating in the deal, according to Charli. Entities affiliated with Capital Group and EQT Ventures will remain Einride’s largest shareholders following the transaction, followed by Alyeska Investment Group . “We chose to prioritize bringing in good investors at a valuation that we felt was appropriate,” the CEO said. The debut will mark the latest test for a business built around electric trucking software and autonomous driving. The truck industry’s transition away from diesel has proved slower and more complicated than Einride initially anticipated, with high vehicle costs and charging infrastructure constraints among the headwinds. Added to that, autonomous-trucking rivals Aurora Innovation Inc. and Kodiak AI Inc. saw weak post-listing performances in the US, underscoring the challenges these companies face in sustaining market valuations. “We’re all going after roughly the same market to some extent,” Charli said. “But we’re approaching it from different angles.”
A cannabis-derived drug for lower back pain will soon go on sale in Germany and Austria in what its developer views as a dry run for launching in the world’s biggest pharma market: the US. Vertanical GmbH , the closely held German firm behind the medicine, won regulatory clearance in the two countries for Exilby. The cannabis extract is being fast-tracked in the US, meaning it could be approved th...
A cannabis-derived drug for lower back pain will soon go on sale in Germany and Austria in what its developer views as a dry run for launching in the world’s biggest pharma market: the US. Vertanical GmbH , the closely held German firm behind the medicine, won regulatory clearance in the two countries for Exilby. The cannabis extract is being fast-tracked in the US, meaning it could be approved there in 2028 or 2029, according to the company. Founder Clemens Fischer says Exilby is a safer alternative to addictive opioids that have been linked to hundreds of thousands of deaths, especially in the US. Besides outshining a placebo in trials, it showed less digestive disturbance than opioids like tramadol and fentanyl. “My number one goal is actually to replace opiates,” Fischer said in an interview. Vertanical isn’t the only company targeting that market. Vertex Pharmaceuticals Inc. ’s Journavx last year became the first new type of painkiller to enter the US market in more than two decades. Exilby won clearance in the two European countries for chronic lower back pain with a neuropathic component. In tests, patients showed no signs of dependence or withdrawal. Vertanical says it screened about 500 cannabis plants to identify one with the genetic profile it wanted, then developed a standardized extract with fixed levels of THC, CBD and other active compounds, according to Fischer. Not every patient will benefit from Exilby, said Winfried Häuser, a pain specialist who was involved in one of the studies. Häuser might prescribe it over other cannabis-based medicines available in Germany depending on the final cost, he said. Vertanical is also preparing to submit the drug in the UK.
[The content of this article has been produced by our advertising partner.] Hong Kong has one of the world’s longest life expectancies, a distinction it has maintained for much of the past decade according to data from the city’s Centre for Health Protection. But longevity alone does not guarantee a healthier, more fulfilling or financially secure life. That reality is becoming increasingly appare...
[The content of this article has been produced by our advertising partner.] Hong Kong has one of the world’s longest life expectancies, a distinction it has maintained for much of the past decade according to data from the city’s Centre for Health Protection. But longevity alone does not guarantee a healthier, more fulfilling or financially secure life. That reality is becoming increasingly apparent across ageing societies, where longer lives are bringing fresh questions about healthcare,...
Wang Chuanfu, chairman of BYD, on Tuesday said he expected the Chinese firm to become the world's largest automaker within five years, as he sought to reassure investors following a steep decline in the company's share price. Shares of the company have dropped more than 45% from their peak in Hong Kong over the past year, while its Shenzhen-listed stock has fallen 33%. Speaking at the company's ...
Wang Chuanfu, chairman of BYD, on Tuesday said he expected the Chinese firm to become the world's largest automaker within five years, as he sought to reassure investors following a steep decline in the company's share price. Shares of the company have dropped more than 45% from their peak in Hong Kong over the past year, while its Shenzhen-listed stock has fallen 33%. Speaking at the company's annual shareholder meeting at its Shenzhen headquarters, Wang addressed nearly 1,000 shareholders, emphasizing a focus on ramping up the output of its second-generation Blade Battery, which he identified as this year's key growth bottleneck, according to the state-owned Shanghai Securities News.
Indonesian assets rebounded after officials stepped up efforts to reassure foreign investors, driving the rupiah to its biggest gain in more than a year while easing pressure on bonds and lifting stocks. The 10-year yield fell 15 basis points on Wednesday to 7.26% after climbing as much as 64 basis points in the past two days. The rupiah strengthened as much as 0.9%, while the benchmark stock inde...
Indonesian assets rebounded after officials stepped up efforts to reassure foreign investors, driving the rupiah to its biggest gain in more than a year while easing pressure on bonds and lifting stocks. The 10-year yield fell 15 basis points on Wednesday to 7.26% after climbing as much as 64 basis points in the past two days. The rupiah strengthened as much as 0.9%, while the benchmark stock index rose 3.4%. Central bank governor Perry Warjiyo led a call with US and European investors late Tuesday to take questions on the rate increase and was set to hold another one on Wednesday morning in Asia. Finance minister Purbaya Yudhi Sadewa reassured lawmakers Tuesday that he will uphold the budget deficit limit, a key concern for fund managers. The rebound offered some relief for Indonesian markets, which have fallen out of favor with global investors concerned over President Prabowo Subianto ’s increasingly interventionist economic agenda. Financial markets will be watching closely for further policy signals from Jakarta after foreign investors pulled a net $3.7 billion from local equities and $594 million from bonds this year. Prabowo Needs More Than Rate Hikes to Fix Market, Analysts Say Indonesia’s Bond Selloff Extends After Off-Cycle Rate Increase Indonesia May Hike Rate Again to Shield Rupiah, Analysts Say